Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Change the shape, defeat the virus! : Antiviral study | Hand, foot, and mouth disease

ICMR-NIN | Senior Research Fellow Recruitment

Plant ABC transporters

Change the shape, defeat the virus! : Antiviral study | Hand, foot, and mouth disease
  • BiotechToday
  • World

Change the shape, defeat the virus! : Antiviral study | Hand, foot, and mouth disease

bioxone September 23, 2020September 23, 2020

-Shristi Sharma, Team bioXone

Researchers from Duke University have found a drug against enterovirus 71, a virus that causes hand, foot, and mouth disease in infants and young children. While many patients recover in a week after sustaining fever and rashes, some even face paralysis and brain edema in severe cases.

The drug compound in interest is a small molecule that shows an affinity towards the virus’s RNA (genetic material). Hereby, binding to it, changes its shape in 3D, giving access to Human repressor proteins that block the ‘reading out’ of the virus’s replication instructions; rendering it harmless for the human host.

There is no FDA approved drug for the disease in the market. Most researchers have mainly targetted protein binding elements, and completely overlooked the potential of small molecules that target RNA.

Hence, the future of drugs may rest upon antiviral treatments, such as binding fragments of compounds that could render the viruses incapable of causing diseases.

Source: Jesse Davila-Calderon, Neeraj N. Patwardhan, Liang-Yuan Chiu, Andrew Sugarman, Zhengguo Cai, Srinivasa R. Penutmutchu, Mei-Ling Li, Gary Brewer, Amanda E. Hargrove, Blanton S. Tolbert. IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex. Nature Communications, 2020; 11 (1) DOI: 10.1038/s41467-020-18594-3

Visit www.bioxone.in for more updates.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged 3d and mouth disease antivirals diseases drug enterovirus 71 foot hand RNA shape Small molecules virus

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Scientists' Corner

Plant ABC transporters

bioxone September 23, 2020

–Dr. Ayan Raichaudhuri & Anuska Sen, Team BioXone The ATP-binding cassette (ABC) protein superfamily present in most eukaryotic and prokaryotic organisms, form one of the largest protein families known, the majority of whose members are membrane proteins (ABC “transporters”). These transporters use ATP to pump molecules across a membrane and so are known to be […]

Related Post

  • BiotechToday
  • World

COVID-19 vaccine for children: Pfizer shows progress!

BioTech Today November 22, 2021November 22, 2021

Ananya Ghosal, MAKAUT(WB) COVID-19 vaccine is still a dream for children under 12. Although children are not at risk of COVID-19 like adults, their reports are still positive. The delta variant and reopening of schools combined and resulted in a keen rise in pediatric COVID-19 cases that is related to the records in the pandemic. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

NANOPARTICLES IN THE SYNTHESIS OF ANTICANCER DRUGS

bioxone December 12, 2020December 12, 2020

AISHILA KAR, AMITY UNIVERSITY KOLKATA Catalysts are extensively used in the production of chemicals and pharmaceutical products. They have the great significance of nanocatalysts in different areas of nanotechnology such as nanochemistry, nanopharmaceuticals, and nanomedicine. Also, developed for cancer treatment based on nanoparticles (NPs) which promote Fenton reaction have been widely used by scientists. Magnetic […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy